piromelatine multimodal sleep drug development neurim pharmaceuticals agonist melatonin serotonin receptors neurim conducting phase ii randomized placebo controlled trial cognitive sleep effects alzheimers disease results phase ii trial insomnia adults announced finding piromelatine mg improved sleep weeks vs phase studies showed safe dosedependent improvement preclinical studies showed cognitive rat disease models pain hypertension alzheimers disease antidepressant antianxiety effects also demonstrated animal drug article relating nervous system stub help wikipedia expanding ithttpsenwikipediaorgwikipiromelatine